Program

ÇмúÇà»ç > ÇÁ·Î±×·¥¾È³»
22ÀÏ Ãß°èÇмú´ëȸ

8¿ù 22ÀÏ(Åä¿äÀÏ) Room A

½Ã°£ ¼¼¼Ç ÁÂÀå/¿¬ÀÚ ¼Ò¼Ó
8:30-9:40 Symposium 3: Personalized Surgical Therapy for Thyroid Cancer Å°æ ÇѾçÀÇ´ë À̺ñÀÎÈÄ°ú
8:30-8:45 Operative Management of Primary Papillary Thyroid Carcinoma ±è¿Ï¿í °æºÏÀÇ´ë ¿Ü°ú
8:45-9:00 Optimal Management for the Locally Invasive Thyroid Cancer ¾È¼øÇö ¼­¿ïÀÇ´ë À̺ñÀÎÈÄ°ú
9:00-9:15 Optimal Neck Dissection: How Much Surgery is Enough for the Node Positive Neck? À̺´ÁÖ ºÎ»êÀÇ´ë À̺ñÀÎÈÄ°ú
9:15-9:30 Intraoperative Neuromonitoring during Thyroid Surgery ±èÈÆ¿± °í·ÁÀÇ´ë ¿Ü°ú
9:45-10:55 Symposium 4: New Insight from Immunity to Thyroid Cancer ÀÌÀçÅ °æºÏÀÇ´ë ÇÙÀÇÇаú
9:45-10:05 Immune Landscape of Papillary Thyroid Cancer and Immunotherapeutic Implications ÃÖÈ«À± ¼­¿ïÀÇ´ë ÇÙÀÇÇаú
10:05-10:25 Co-Expression Network Analysis with Proteogenomics Identifies Important Transcriptional Factors in Tumorigenesis and Progression of BRAFV600E Mutated Thyroid Cancer ±èÀ¯Çü ¼­¿ïÀÇ´ë ³»°ú
10:25-10:45 Macrophage-Derived Endotrophin Supports Tumor Migration Potentials in Thyroid Cancer ½ÅÈ¿½Ä ¼­¿ïÀÇ´ë ³»°ú
10:55-11:15 Coffee Break ¡¡ ¡¡
11:15-12:15 Plenary Lecture ÀåÇ×¼® ¿¬¼¼ÀÇ´ë ¿Ü°ú
¡¡ Current Surgical Management of Thyroid Cancer in the United States Quan-Yang Duh  University of California, San Francisco, USA
12:15-12:45 ÃÑȸ ¡¡ ¡¡
12:45-13:15 Luncheon Symposium  Á¤À±Àç Áß¾ÓÀÇ´ë ³»°ú
¡¡ Metabolic Issues to Consider When Treating Patients with Thyroid Disease ÀÌÀº°æ ±¹¸³¾Ï¼¾ÅÍ ³»°ú
13:30-14:10 ¹ü»ê Çмú»ó ÀÌ°­´ë °í½ÅÀÇ´ë À̺ñÀÎÈÄ°ú(KTA ȸÀå)
¡¡ Metastatic Follicular Carcinoma in Pelvic Cavity Arising from Struma Ovarii Á¤Á¾±æ ¿©¼öÀü³²º´¿ø ¿Ü°ú
14:15-15:00 Presidential Lecture ¾Èº´Ã¶ °æºÏÀÇ´ë ÇÙÀÇÇаú
¡¡ Development of New Technologies on the Preservation of the Parathyroid Gland and Recurrent Laryngeal Nerve during Thyroid and Parathyroid Surgery ÀÌ°­´ë °í½ÅÀÇ´ë À̺ñÀÎÈÄ°ú
15:00-15:20 Coffee Break ¡¡ ¡¡
15:20-16:30 Symposium 5: How to Deal with PTMC in Radiology ³ªµ¿±Ô °­¸ª¾Æ»êº´¿ø ¿µ»óÀÇÇаú
¼ºÁø¿ë ´ë¸²¼º¸ðº´¿ø ¿µ»óÀÇÇаú
15:20-15:40 Role of Thyroid US and CT in Active Surveillance of Low-Risk PTMC ¾ÈÇý½Å Áß¾ÓÀÇ´ë ¿µ»óÀÇÇаú
15:40-16:00 Interventional Management of Low-Risk PTMC ÇÏÀºÁÖ ¾ÆÁÖÀÇ´ë ¿µ»óÀÇÇаú
16:00-16:20 Current Stance on Active Surveillance of Low-Risk PTMC ¼Û¿µ±â ¿ï»êÀÇ´ë ³»°ú
16:35-17:45 Topic Highlight ¾Èº´Ã¶ °æºÏÀÇ´ë ÇÙÀÇÇаú
16:35-16:50 Long-Term Quality of Life According to the Treatment Options in Patients with Low Risk Papillary Thyroid Carcinoma - Results from the Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro) ¹®ÀçÈÆ ¼­¿ïÀÇ´ë ³»ºÐºñ³»°ú
16:50-17:05 Radiomics Based on Thyroid Ultrasound Can Predict Distant Metastasis of Follicular Thyroid Carcinoma ±Ç¹Ì¸® ¼º±Õ°üÀÇ´ë ¿µ»óÀÇÇаú
17:05-17:20 Immune Profiling of Advanced Thyroid Cancers Using Fluorescent Multiplex Immunohistochemistry  ¾ÈÁ¾È­  ¿ï»êÀÇ´ë ³»ºÐºñ³»°ú
17:20-17:45 Adaptation of Murine Anaplastic Thyroid Cancer Cell Line from Hybrid Mice to Inbred C57BL/6 Mice ÇϼºÀ± ¼­¿ïÀÇ´ë Á¾¾ç»ý¹°Çаú
17:45 Æóȸ ¹× ½Ã»ó½Ä ¡¡ ¡¡

8¿ù 22ÀÏ(Åä¿äÀÏ) Room B

8:30-9:10 Free Paper 2 Á¤¼Ò·É °¡Å縯ÀÇ´ë ¿µ»óÀÇÇаú
±èÀÎÁÖ ºÎ»êÀÇ´ë ³»°ú
9:10-9:50 Free Paper 3 Á¶¿µ¼® ¿¬¼¼ÀÇ´ë ³»°ú
ÀÓÀÏÇÑ ¿øÀڷº´¿ø ÇÙÀÇÇаú